Lung-Heart Outcomes and Mortality through the 2020 COVID-19 Pandemic in a Prospective Cohort of Breast Cancer Radiotherapy Patients

Lung-Heart Outcomes and Mortality through the 2020 COVID-19 Pandemic in a Prospective Cohort of Breast Cancer Radiotherapy Patients

We investigated lung-heart toxicity and mortality in 123 women with stage I-II breast cancer enrolled in 2007–2011 in a prospective trial of adjuvant radiotherapy (TomoBreast). We were concerned whether the COVID-19 pandemic affected the outcomes. All patients were analyzed as a single cohort. Lung-...

Full description

Bibliographic Details
Main Authors: Vincent Vinh-Hung, Olena Gorobets, Nele Adriaenssens, Hilde Van Parijs, Guy Storme, Dirk Verellen, Nam P. Nguyen, Nicolas Magne, Mark De Ridder
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Cancers
Subjects:
COVID-19
longitudinal analysis
cohort monitoring
outlier’s test
hybrid prospective-retrospective study
adjuvant radiotherapy
Online Access:https://www.mdpi.com/2072-6694/14/24/6241

Internet

https://www.mdpi.com/2072-6694/14/24/6241

Similar Items